Dashboard
Program Home
Faculty
IPTA 2025 Website
Login
Dashboard
Program Home
Faculty
IPTA 2025 Website
Login
Primary hyperoxaluria: Therapeutic options to surpass inequities in access
Friday September 19, 2025 - 14:10 to 15:10
Room: MOA 6
230.1 Treatment of choice – siRNAs, The Cure?
Log in to add to favorites
Add Personal Notes
Bernd Hoppe, Germany
Head
German Hyperoxaluria Center
Pediatric Nephrology Center Bonn
Presentations by Bernd Hoppe
Fri-19 from 14:10 - 15:10 in room MOA 6
Primary hyperoxaluria: Therapeutic options to surpass inequities in access
Treatment of choice – siRNAs, The Cure?
Email:
info@ipta2025.org
514-874-1717
